{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:03:33Z","timestamp":1791493413239,"version":"4.3.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"\n Context<\/jats:title>\n New therapeutic strategies have developed for the management of acromegaly over recent decades. Whether this has improved mortality has not been fully elucidated.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The primary aim was to investigate mortality in a nationwide unselected cohort of patients with acromegaly. Secondary analyses included time trends in mortality and treatment patterns.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A total of 1089 patients with acromegaly were identified in Swedish National Health Registries between 1987 and 2013. To analyse time trends, the cohort was divided into three periods (1987\u20131995, 1996\u20132004 and 2005\u20132013) based on the year of diagnosis.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n Using the Swedish population as reference, standardized mortality ratios (SMRs) were calculated with 95% confidence intervals (CIs).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Overall SMR was 2.79 (95% CI: 2.43\u20133.15) with 232 observed and 83 expected deaths. Mortality was mainly related to circulatory diseases (SMR: 2.95, 95% CI: 2.35\u20133.55), including ischemic heart disease (2.00, 1.35\u20132.66) and cerebrovascular disease (3.99, 2.42\u20135.55) and malignancy (1.76, 1.27\u20132.26). Mortality decreased over time, with an SMR of 3.45 (2.87\u20134.02) and 1.86 (1.04\u20132.67) during the first and last time period, respectively (\n P<\/jats:italic>\n \u2009=\u2009.015). During the same time periods, the frequency of pituitary surgery increased from 58% to 72% (\n P<\/jats:italic>\n \u2009<\u20090.001) and the prevalence of hypopituitarism decreased from 41% to 23% (\n P<\/jats:italic>\n \u2009<\u20090.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Excess mortality was found in this nationwide cohort of patients with acromegaly, mainly related to circulatory and malignant diseases. Although still high, mortality significantly declined over time. This could be explained by the more frequent use of pituitary surgery, decreased prevalence of hypopituitarism and the availability of new medical treatment options.<\/jats:p>\n <\/jats:sec>","DOI":"10.1530\/eje-18-0015","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T20:35:20Z","timestamp":1519677320000},"page":"459-469","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":95,"title":["Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study"],"prefix":"10.1093","volume":"178","author":[{"given":"Daniela","family":"Esposito","sequence":"first","affiliation":[{"name":"1Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[{"name":"1Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Granfeldt","sequence":"additional","affiliation":[{"name":"2Nordic Health Economics, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Marlow","sequence":"additional","affiliation":[{"name":"2Nordic Health Economics, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"1Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S","family":"Olsson","sequence":"additional","affiliation":[{"name":"1Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"ref91","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1210\/jc.2004-0669","article-title":"Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess.","volume":"89","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref101","first-page":"1","article-title":"Mortality in acromegaly","volume":"39","year":"1970","journal-title":"Quarterly Journal of Medicine"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register.","volume":"11","year":"2011","journal-title":"BMC Public Health"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates.","volume":"326","year":"2003","journal-title":"BMJ"},{"key":"ref51","first-page":"102","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management.","year":"2004","journal-title":"Endocrine Reviews"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism.","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-12-0084","article-title":"Predictors of morbidity and mortality in acromegaly: an Italian survey.","volume":"167","year":"2012","journal-title":"European Journal of Endocrinology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/EJE-14-0144","article-title":"The incidence rate of pituitary adenomas in western Sweden for the period 2001\u20132011.","volume":"171","year":"2014","journal-title":"European Journal of Endocrinology"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-16-1064","article-title":"Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry.","volume":"176","year":"2017","journal-title":"European Journal of Endocrinology"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11102-012-0384-x","article-title":"Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA).","volume":"16","year":"2013","journal-title":"Pituitary"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/EJE-16-0623","article-title":"Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study.","volume":"176","year":"2017","journal-title":"European Journal of Endocrinology"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database.","volume":"24","year":"2017","journal-title":"Endocrine-Related Cancer"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/EJE-12-0602","article-title":"Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register.","volume":"168","year":"2013","journal-title":"European Journal of Endocrinology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study.","volume":"175","year":"2016","journal-title":"European Journal of Endocrinology"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.","volume":"94","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1210\/jc.2015-1475","article-title":"Excess mortality in women and young adults with nonfunctioning pituitary adenoma: a Swedish Nationwide Study","volume":"100","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cen.12112","article-title":"Emerging trends in the diagnosis and treatment of acromegaly in Canada","volume":"79","year":"2013","journal-title":"Clinical Endocrinology"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly.","volume":"89","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline.","volume":"99","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","article-title":"Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.","volume":"89","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1210\/jcem.86.7.7635","article-title":"Acromegaly and cancer: not a problem?","volume":"86","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1210\/jc.2004-2297","article-title":"Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life.","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/jc.2014-3525","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.","volume":"100","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11102-015-0701-2","article-title":"Incidence and prevalence of acromegaly in a large US health plan database.","volume":"19","year":"2016","journal-title":"Pituitary"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-07-0358","article-title":"AcroBel \u2013 the Belgian registry on acromegaly: a survey of the \u2018real-life\u2019 outcome in 418 acromegalic subjects.","volume":"157","year":"2007","journal-title":"European Journal of Endocrinology"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/jc.2003-032041","article-title":"Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements.","volume":"89","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11102-012-0412-x","article-title":"Acromegalic patients lost to follow-up: a pilot study","volume":"16","year":"2013","journal-title":"Pituitary"},{"key":"ref191","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.","volume":"83","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref221","doi-asserted-by":"publisher","first-page":"2016175","DOI":"10.1530\/EJE-16-0178","article-title":"BoguszewskiCLAyukJ of endocrine disease acromegaly and cancer an old debate revisited of https org","journal-title":"Management European Journal Endocrinology"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ghir.2017.08.003","article-title":"The impact of adjustments to the diagnostic criteria for biochemical remission in surgically treated patients with acromegaly.","volume":"36","year":"2017","journal-title":"Growth Hormone and IGF Research"},{"key":"ref281","first-page":"439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA).","volume":"151","year":"2004","journal-title":"European Journal of Endocrinology"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1210\/jc.2014-3787","article-title":"Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies.","volume":"100","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref231","first-page":"469","article-title":"Mortality in acromegaly: a 20-year follow-up study.","volume":"23","year":"2015","journal-title":"Endocrine-Related Cancer"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03344942","article-title":"Acromegaly: an epidemiological study.","volume":"16","year":"1993","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1530\/EJE-13-0924","article-title":"Patients lost to follow-up in acromegaly: results of the ACROSPECT study","volume":"170","year":"2014","journal-title":"European Journal of Endocrinology"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease.","volume":"31","year":"2010","journal-title":"Endocrine Reviews"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/178\/5\/EJE-18-0015.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/EJE-18-0015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:11:46Z","timestamp":1676373106000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/178\/5\/459\/6655312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":38,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1530\/eje-18-0015","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732763512.793576586","asserted-by":"object"}]},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}